Responsibilities
- Drive multiple myeloma CAR-T brand choice within authorized treatment centers (ATCs) and community-based accounts.
- Competitively sell Arcellx products through a deep knowledge of the multiple myeloma landscape and best-in-class clinical expertise.
- Effectively navigate complex account environments by identifying and understanding the needs and challenges of diverse stakeholders and collaborate with internal teams to provide targeted support.
- Integrate customer insights and analytical data to design and execute strategic account plans. Develop a deep understanding of customer dynamics and market trends to identify opportunities, uncover barriers to treatment, and drive actionable insights.
- Share relevant account and HCP insights with cross-functional and alliance partners, highlighting business trends, competitive shifts, and changes in the therapeutic landscape. Support alliance partners to ensure the patient experience is positive and seamless.
- Equip ATC staff with CAR-T process training that will eliminate barriers to use and optimize operational workflows.
- Operate in strict compliance with all laws, regulations, company policies, and ethical standards, including protection of patient-identifiable data.
Requirements
- Master’s or bachelor’s degree required.
- 5+ years of hematology/oncology therapeutic experience required.
- Proven and consistent history of meeting or exceeding sales objectives in complex, competitive, high-value therapeutic areas.
- Demonstrated ability to manage large, strategic accounts and navigate complex academic hospital systems in collaboration with cross-functional and co-marketing partners.
Nice to Have
- Experience in cell therapy, immunotherapy, and/or multiple myeloma strongly preferred, along with a strong understanding of oncology market dynamics.
- Experience with new product launches within academic hospitals or specialty markets is strongly preferred.
Work Arrangement
Remote (City/Region)
Additional Information
- Willingness to travel overnight up to 50%.
